Loading…

Gegen Qinlian Decoction Downregulates the TLR7 Signalling Pathway to Control Influenza A Virus Infection

•Gegen Qinlian decoction of influenza is mediated by the TLR7 pathway, and Gegen Qinlian decoction downregulated the expression of some key TLR7 signalling pathway factors.•Influenza viruses cause immune imbalances and Gegen Qinlian decoction also affected the differentiation of CD4+ T cells.•Gegen...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicine & pharmacotherapy 2020-01, Vol.121, p.109471-109471, Article 109471
Main Authors: Shi, Yucong, Xu, Huachong, Xiao, Yike, Liu, Pei, Pang, Peng, Wu, Sizhi, Deng, Li, Chen, Xiaoyin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c385t-f68a38eed02609c9478eeef846b07c68ad65ae1866b25357468f3e9d99afcd2a3
cites cdi_FETCH-LOGICAL-c385t-f68a38eed02609c9478eeef846b07c68ad65ae1866b25357468f3e9d99afcd2a3
container_end_page 109471
container_issue
container_start_page 109471
container_title Biomedicine & pharmacotherapy
container_volume 121
creator Shi, Yucong
Xu, Huachong
Xiao, Yike
Liu, Pei
Pang, Peng
Wu, Sizhi
Deng, Li
Chen, Xiaoyin
description •Gegen Qinlian decoction of influenza is mediated by the TLR7 pathway, and Gegen Qinlian decoction downregulated the expression of some key TLR7 signalling pathway factors.•Influenza viruses cause immune imbalances and Gegen Qinlian decoction also affected the differentiation of CD4+ T cells.•Gegen Qinlian decoction activated a balanced inflammatory response in the host to limit immune pathological injury and improve clinical and survival outcomes. In recent years, Gegen Qinlian decoction (GQD) has been applied to treat influenza virus infection, and its clinical effectiveness has been shown. However, the potential mechanism by which GQD acts on influenza A virus (IAV) has not been fully elucidated. Traditional Chinese medicine (TCM) formulas are well known to have multiple targets and effects. Our previous experiments examined the mechanism by which TCM can be used to treat influenza from the perspective of the influenza immune mechanism. To explore the possible mechanism by which GQD affects mice infected with the FM1 strain of influenza virus. Forty-eight C57BL/6 mice were divided randomly into four groups: a normal control (NG) group, an IAV infection (VG) group, an IAV + oseltamivir (30.44 mg/kg) treatment (VO) group, and an IAV + GQD (9.74 g/kg) treatment (VQ) group. We also grouped forty-eight Toll-like receptor 7 knockout (TLR7−/−) mice in the same manner. The pulmonary mRNA expression of TLR7, myeloid differentiation factor 88 (MyD88), and nuclear factor (NF)-κB p65 was measured by RT-qPCR, and the pulmonary protein expression of TLR7, MyD88, and NF-κB p65 was measured by western blot. The proportions of T helper (Th) 1, Th2, Th17 and regulatory T (Treg) cells were measured by flow cytometry. IAV infection led to low body weights and high viral load. Compared with those in the NG group, the mRNA expression levels of TLR7, MyD88, and NF-κB p65 in the VG group were upregulated (P 
doi_str_mv 10.1016/j.biopha.2019.109471
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2313655710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0753332219336352</els_id><sourcerecordid>2313655710</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-f68a38eed02609c9478eeef846b07c68ad65ae1866b25357468f3e9d99afcd2a3</originalsourceid><addsrcrecordid>eNp9UMtOwzAQtBBIlMcfcPCRS4od105yQUIFSqVKvLlarrNJXRm72AmofD0u4cxpd2dnRppB6IySMSVUXKzHS-M3KzXOCa0SVE0KuodGtOIkE4QU-2hECs4yxvL8EB3FuCaEcMHKEVrNoAWHH42zRjl8Ddrrzvi0-S8XoO2t6iDibgX4ZfFU4GfTOmWtcS1-UN3qS21x5_HUuy54i-eusT24b4Wv8JsJfdwh8Gt4gg4aZSOc_s1j9Hp78zK9yxb3s_n0apFpVvIua0SpWAlQk1yQSqck6YCmnIglKXR61oIroKUQy5wzXkxE2TCo6qpSja5zxY7R-eC7Cf6jh9jJdxM1WKsc-D7KnFEmOC8oSdTJQNXBxxigkZtg3lXYSkrkrli5lkOxclesHIpNsstBBinGp4EgozbgNNQmpKyy9uZ_gx_JiYPP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2313655710</pqid></control><display><type>article</type><title>Gegen Qinlian Decoction Downregulates the TLR7 Signalling Pathway to Control Influenza A Virus Infection</title><source>ScienceDirect Journals</source><creator>Shi, Yucong ; Xu, Huachong ; Xiao, Yike ; Liu, Pei ; Pang, Peng ; Wu, Sizhi ; Deng, Li ; Chen, Xiaoyin</creator><creatorcontrib>Shi, Yucong ; Xu, Huachong ; Xiao, Yike ; Liu, Pei ; Pang, Peng ; Wu, Sizhi ; Deng, Li ; Chen, Xiaoyin</creatorcontrib><description>•Gegen Qinlian decoction of influenza is mediated by the TLR7 pathway, and Gegen Qinlian decoction downregulated the expression of some key TLR7 signalling pathway factors.•Influenza viruses cause immune imbalances and Gegen Qinlian decoction also affected the differentiation of CD4+ T cells.•Gegen Qinlian decoction activated a balanced inflammatory response in the host to limit immune pathological injury and improve clinical and survival outcomes. In recent years, Gegen Qinlian decoction (GQD) has been applied to treat influenza virus infection, and its clinical effectiveness has been shown. However, the potential mechanism by which GQD acts on influenza A virus (IAV) has not been fully elucidated. Traditional Chinese medicine (TCM) formulas are well known to have multiple targets and effects. Our previous experiments examined the mechanism by which TCM can be used to treat influenza from the perspective of the influenza immune mechanism. To explore the possible mechanism by which GQD affects mice infected with the FM1 strain of influenza virus. Forty-eight C57BL/6 mice were divided randomly into four groups: a normal control (NG) group, an IAV infection (VG) group, an IAV + oseltamivir (30.44 mg/kg) treatment (VO) group, and an IAV + GQD (9.74 g/kg) treatment (VQ) group. We also grouped forty-eight Toll-like receptor 7 knockout (TLR7−/−) mice in the same manner. The pulmonary mRNA expression of TLR7, myeloid differentiation factor 88 (MyD88), and nuclear factor (NF)-κB p65 was measured by RT-qPCR, and the pulmonary protein expression of TLR7, MyD88, and NF-κB p65 was measured by western blot. The proportions of T helper (Th) 1, Th2, Th17 and regulatory T (Treg) cells were measured by flow cytometry. IAV infection led to low body weights and high viral load. Compared with those in the NG group, the mRNA expression levels of TLR7, MyD88, and NF-κB p65 in the VG group were upregulated (P &lt; 0.05). However, the mRNA and protein expression levels of TLR7, MyD88, and NF-κB p65 were lower in the VO and VQ groups than in the VG group (P &lt; 0.05). IAV infection led to increased proportions of Th1/Th2 and Th17/Treg cells in the VG group. In the VO and VQ groups, both Th2 and Th1 cell numbers were increased, resulting in a lower Th1/Th2 proportion than that in the VG group. GQD downregulated the expression of some key TLR signalling pathway factors. GQD also affected the differentiation of CD4+ T cells, thereby exerting a protective systemic effect on influenza virus infection. In conclusion, GQD activated a balanced inflammatory response in the host to limit immune pathological injury and improve clinical and survival outcomes.</description><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2019.109471</identifier><language>eng</language><publisher>Elsevier Masson SAS</publisher><subject>Gegen qinlian decoction ; Influenza virus ; TLR7</subject><ispartof>Biomedicine &amp; pharmacotherapy, 2020-01, Vol.121, p.109471-109471, Article 109471</ispartof><rights>2019 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-f68a38eed02609c9478eeef846b07c68ad65ae1866b25357468f3e9d99afcd2a3</citedby><cites>FETCH-LOGICAL-c385t-f68a38eed02609c9478eeef846b07c68ad65ae1866b25357468f3e9d99afcd2a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids></links><search><creatorcontrib>Shi, Yucong</creatorcontrib><creatorcontrib>Xu, Huachong</creatorcontrib><creatorcontrib>Xiao, Yike</creatorcontrib><creatorcontrib>Liu, Pei</creatorcontrib><creatorcontrib>Pang, Peng</creatorcontrib><creatorcontrib>Wu, Sizhi</creatorcontrib><creatorcontrib>Deng, Li</creatorcontrib><creatorcontrib>Chen, Xiaoyin</creatorcontrib><title>Gegen Qinlian Decoction Downregulates the TLR7 Signalling Pathway to Control Influenza A Virus Infection</title><title>Biomedicine &amp; pharmacotherapy</title><description>•Gegen Qinlian decoction of influenza is mediated by the TLR7 pathway, and Gegen Qinlian decoction downregulated the expression of some key TLR7 signalling pathway factors.•Influenza viruses cause immune imbalances and Gegen Qinlian decoction also affected the differentiation of CD4+ T cells.•Gegen Qinlian decoction activated a balanced inflammatory response in the host to limit immune pathological injury and improve clinical and survival outcomes. In recent years, Gegen Qinlian decoction (GQD) has been applied to treat influenza virus infection, and its clinical effectiveness has been shown. However, the potential mechanism by which GQD acts on influenza A virus (IAV) has not been fully elucidated. Traditional Chinese medicine (TCM) formulas are well known to have multiple targets and effects. Our previous experiments examined the mechanism by which TCM can be used to treat influenza from the perspective of the influenza immune mechanism. To explore the possible mechanism by which GQD affects mice infected with the FM1 strain of influenza virus. Forty-eight C57BL/6 mice were divided randomly into four groups: a normal control (NG) group, an IAV infection (VG) group, an IAV + oseltamivir (30.44 mg/kg) treatment (VO) group, and an IAV + GQD (9.74 g/kg) treatment (VQ) group. We also grouped forty-eight Toll-like receptor 7 knockout (TLR7−/−) mice in the same manner. The pulmonary mRNA expression of TLR7, myeloid differentiation factor 88 (MyD88), and nuclear factor (NF)-κB p65 was measured by RT-qPCR, and the pulmonary protein expression of TLR7, MyD88, and NF-κB p65 was measured by western blot. The proportions of T helper (Th) 1, Th2, Th17 and regulatory T (Treg) cells were measured by flow cytometry. IAV infection led to low body weights and high viral load. Compared with those in the NG group, the mRNA expression levels of TLR7, MyD88, and NF-κB p65 in the VG group were upregulated (P &lt; 0.05). However, the mRNA and protein expression levels of TLR7, MyD88, and NF-κB p65 were lower in the VO and VQ groups than in the VG group (P &lt; 0.05). IAV infection led to increased proportions of Th1/Th2 and Th17/Treg cells in the VG group. In the VO and VQ groups, both Th2 and Th1 cell numbers were increased, resulting in a lower Th1/Th2 proportion than that in the VG group. GQD downregulated the expression of some key TLR signalling pathway factors. GQD also affected the differentiation of CD4+ T cells, thereby exerting a protective systemic effect on influenza virus infection. In conclusion, GQD activated a balanced inflammatory response in the host to limit immune pathological injury and improve clinical and survival outcomes.</description><subject>Gegen qinlian decoction</subject><subject>Influenza virus</subject><subject>TLR7</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9UMtOwzAQtBBIlMcfcPCRS4od105yQUIFSqVKvLlarrNJXRm72AmofD0u4cxpd2dnRppB6IySMSVUXKzHS-M3KzXOCa0SVE0KuodGtOIkE4QU-2hECs4yxvL8EB3FuCaEcMHKEVrNoAWHH42zRjl8Ddrrzvi0-S8XoO2t6iDibgX4ZfFU4GfTOmWtcS1-UN3qS21x5_HUuy54i-eusT24b4Wv8JsJfdwh8Gt4gg4aZSOc_s1j9Hp78zK9yxb3s_n0apFpVvIua0SpWAlQk1yQSqck6YCmnIglKXR61oIroKUQy5wzXkxE2TCo6qpSja5zxY7R-eC7Cf6jh9jJdxM1WKsc-D7KnFEmOC8oSdTJQNXBxxigkZtg3lXYSkrkrli5lkOxclesHIpNsstBBinGp4EgozbgNNQmpKyy9uZ_gx_JiYPP</recordid><startdate>202001</startdate><enddate>202001</enddate><creator>Shi, Yucong</creator><creator>Xu, Huachong</creator><creator>Xiao, Yike</creator><creator>Liu, Pei</creator><creator>Pang, Peng</creator><creator>Wu, Sizhi</creator><creator>Deng, Li</creator><creator>Chen, Xiaoyin</creator><general>Elsevier Masson SAS</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202001</creationdate><title>Gegen Qinlian Decoction Downregulates the TLR7 Signalling Pathway to Control Influenza A Virus Infection</title><author>Shi, Yucong ; Xu, Huachong ; Xiao, Yike ; Liu, Pei ; Pang, Peng ; Wu, Sizhi ; Deng, Li ; Chen, Xiaoyin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-f68a38eed02609c9478eeef846b07c68ad65ae1866b25357468f3e9d99afcd2a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Gegen qinlian decoction</topic><topic>Influenza virus</topic><topic>TLR7</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shi, Yucong</creatorcontrib><creatorcontrib>Xu, Huachong</creatorcontrib><creatorcontrib>Xiao, Yike</creatorcontrib><creatorcontrib>Liu, Pei</creatorcontrib><creatorcontrib>Pang, Peng</creatorcontrib><creatorcontrib>Wu, Sizhi</creatorcontrib><creatorcontrib>Deng, Li</creatorcontrib><creatorcontrib>Chen, Xiaoyin</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine &amp; pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shi, Yucong</au><au>Xu, Huachong</au><au>Xiao, Yike</au><au>Liu, Pei</au><au>Pang, Peng</au><au>Wu, Sizhi</au><au>Deng, Li</au><au>Chen, Xiaoyin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gegen Qinlian Decoction Downregulates the TLR7 Signalling Pathway to Control Influenza A Virus Infection</atitle><jtitle>Biomedicine &amp; pharmacotherapy</jtitle><date>2020-01</date><risdate>2020</risdate><volume>121</volume><spage>109471</spage><epage>109471</epage><pages>109471-109471</pages><artnum>109471</artnum><issn>0753-3322</issn><eissn>1950-6007</eissn><abstract>•Gegen Qinlian decoction of influenza is mediated by the TLR7 pathway, and Gegen Qinlian decoction downregulated the expression of some key TLR7 signalling pathway factors.•Influenza viruses cause immune imbalances and Gegen Qinlian decoction also affected the differentiation of CD4+ T cells.•Gegen Qinlian decoction activated a balanced inflammatory response in the host to limit immune pathological injury and improve clinical and survival outcomes. In recent years, Gegen Qinlian decoction (GQD) has been applied to treat influenza virus infection, and its clinical effectiveness has been shown. However, the potential mechanism by which GQD acts on influenza A virus (IAV) has not been fully elucidated. Traditional Chinese medicine (TCM) formulas are well known to have multiple targets and effects. Our previous experiments examined the mechanism by which TCM can be used to treat influenza from the perspective of the influenza immune mechanism. To explore the possible mechanism by which GQD affects mice infected with the FM1 strain of influenza virus. Forty-eight C57BL/6 mice were divided randomly into four groups: a normal control (NG) group, an IAV infection (VG) group, an IAV + oseltamivir (30.44 mg/kg) treatment (VO) group, and an IAV + GQD (9.74 g/kg) treatment (VQ) group. We also grouped forty-eight Toll-like receptor 7 knockout (TLR7−/−) mice in the same manner. The pulmonary mRNA expression of TLR7, myeloid differentiation factor 88 (MyD88), and nuclear factor (NF)-κB p65 was measured by RT-qPCR, and the pulmonary protein expression of TLR7, MyD88, and NF-κB p65 was measured by western blot. The proportions of T helper (Th) 1, Th2, Th17 and regulatory T (Treg) cells were measured by flow cytometry. IAV infection led to low body weights and high viral load. Compared with those in the NG group, the mRNA expression levels of TLR7, MyD88, and NF-κB p65 in the VG group were upregulated (P &lt; 0.05). However, the mRNA and protein expression levels of TLR7, MyD88, and NF-κB p65 were lower in the VO and VQ groups than in the VG group (P &lt; 0.05). IAV infection led to increased proportions of Th1/Th2 and Th17/Treg cells in the VG group. In the VO and VQ groups, both Th2 and Th1 cell numbers were increased, resulting in a lower Th1/Th2 proportion than that in the VG group. GQD downregulated the expression of some key TLR signalling pathway factors. GQD also affected the differentiation of CD4+ T cells, thereby exerting a protective systemic effect on influenza virus infection. In conclusion, GQD activated a balanced inflammatory response in the host to limit immune pathological injury and improve clinical and survival outcomes.</abstract><pub>Elsevier Masson SAS</pub><doi>10.1016/j.biopha.2019.109471</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0753-3322
ispartof Biomedicine & pharmacotherapy, 2020-01, Vol.121, p.109471-109471, Article 109471
issn 0753-3322
1950-6007
language eng
recordid cdi_proquest_miscellaneous_2313655710
source ScienceDirect Journals
subjects Gegen qinlian decoction
Influenza virus
TLR7
title Gegen Qinlian Decoction Downregulates the TLR7 Signalling Pathway to Control Influenza A Virus Infection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T01%3A00%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gegen%20Qinlian%20Decoction%20Downregulates%20the%20TLR7%20Signalling%20Pathway%20to%20Control%20Influenza%20A%20Virus%20Infection&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Shi,%20Yucong&rft.date=2020-01&rft.volume=121&rft.spage=109471&rft.epage=109471&rft.pages=109471-109471&rft.artnum=109471&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2019.109471&rft_dat=%3Cproquest_cross%3E2313655710%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c385t-f68a38eed02609c9478eeef846b07c68ad65ae1866b25357468f3e9d99afcd2a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2313655710&rft_id=info:pmid/&rfr_iscdi=true